Skip to content

IGC PHARMA, INC.: 10-Q filed 2013-11-08

What IGC PHARMA, INC. reported in its quarterly report filed 2013-11-08 (fiscal Q2 2013): 42 published measures, 110 facts as tagged in accession 0001185185-13-002348.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-08
Fiscal period
fiscal Q2 2013
Accession
0001185185-13-002348 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IGC PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3018,541,672USD
At 2013-03-3119,252,593USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-304,076,652USD
At 2013-03-314,278,363USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-3013,925,928USD
At 2013-03-3114,436,130USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-30726,768USD
At 2013-03-311,064,421USD
At 2012-09-30611,297USD
At 2012-03-31562,948USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-615,187USD92
2013-04-01 to 2013-09-30-1,248,674USD183
2012-07-01 to 2012-09-30-142,708USD92
2012-04-01 to 2012-09-30-671,025USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-415,842USD183
2012-04-01 to 2012-09-30-235,607USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,133,585USD92
2013-04-01 to 2013-09-302,257,489USD183
2012-07-01 to 2012-09-301,351,466USD92
2012-04-01 to 2012-09-302,619,146USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-04-01 to 2013-09-30-101,999USD183
2012-04-01 to 2012-09-30-25,137USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-04-01 to 2013-09-30201,998USD183
2012-04-01 to 2012-09-30312,535USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-40,945,853USD
At 2013-03-31-39,697,179USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-07-01 to 2013-09-307,116,180shares92
2013-04-01 to 2013-09-307,116,180shares183
2012-07-01 to 2012-09-306,006,174shares92
2012-04-01 to 2012-09-306,006,174shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-07-01 to 2013-09-307,116,180shares92
2013-04-01 to 2013-09-307,116,180shares183
2012-07-01 to 2012-09-306,006,174shares92
2012-04-01 to 2012-09-306,006,174shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-0.09USD/shares92
2013-04-01 to 2013-09-30-0.18USD/shares183
2012-07-01 to 2012-09-30-0.02USD/shares92
2012-04-01 to 2012-09-30-0.11USD/shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-0.09USD/shares92
2013-04-01 to 2013-09-30-0.18USD/shares183
2012-07-01 to 2012-09-30-0.02USD/shares92
2012-04-01 to 2012-09-30-0.11USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,507USD92
2013-04-01 to 2013-09-303,103USD183
2012-07-01 to 2012-09-309,735USD92
2012-04-01 to 2012-09-30-21,975USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-307,997,727USD
At 2013-03-318,184,230USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-04-01 to 2013-09-30149,830USD183
2012-04-01 to 2012-09-300USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-432,709USD92
2013-04-01 to 2013-09-30-693,463USD183
2012-07-01 to 2012-09-30-343,799USD92
2012-04-01 to 2012-09-30-537,932USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-303,857,366USD
At 2013-03-314,268,645USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-3068,828USD92
2013-04-01 to 2013-09-30180,964USD183
2012-07-01 to 2012-09-3015,740USD92
2012-04-01 to 2012-09-3026,298USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-303,427,932USD
At 2013-03-313,624,975USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-30587,021USD
At 2013-03-31600,702USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-30985,743USD
At 2013-03-311,066,650USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-30503,034USD
At 2013-03-31407,060USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-07-01 to 2013-09-30943,493USD92
2013-04-01 to 2013-09-301,879,732USD183
2012-07-01 to 2012-09-301,108,357USD92
2012-04-01 to 2012-09-302,045,801USD183

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-07-01 to 2013-09-30474,951USD92
2013-04-01 to 2013-09-30774,076USD183
2012-07-01 to 2012-09-30341,783USD92
2012-04-01 to 2012-09-30782,558USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-307,481,426shares
At 2013-03-316,980,098shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3056,677,008USD
At 2013-03-3156,153,375USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-09-30-1,805,975USD
At 2013-03-31-2,020,764USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2013-09-3014,465,020USD
At 2013-03-3114,974,230USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-3016,076,548USD
At 2013-03-3116,101,488USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-30-8,078,821USD
At 2013-03-31-7,917,258USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-30396,117USD
At 2013-03-31466,105USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-30648,720USD
At 2013-03-31653,388USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-30474,738USD
At 2013-03-31466,960USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-09-301,641,821USD
At 2013-03-311,730,514USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-615,368USD92
2013-04-01 to 2013-09-30-1,247,682USD183
2012-07-01 to 2012-09-30-164,899USD92
2012-04-01 to 2012-09-30-705,654USD183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-04-01 to 2013-09-30297,144USD183
2012-04-01 to 2012-09-30328,719USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-04-01 to 2013-09-30297,144USD183
2012-04-01 to 2012-09-30328,719USD183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-04-01 to 2013-09-303,103USD183
2012-04-01 to 2012-09-30-498USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-09-305,828USD183
2012-04-01 to 2012-09-30-4,830USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-09-3095,972USD183
2012-04-01 to 2012-09-3045,380USD183

Inspect the source

Entity
IGC PHARMA, INC. / CIK 0001326205
Captured
2026-09-19T11:17:33.392Z
SEC response SHA-256
b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))